Rapid Health Technology Assessment of Serplulimab as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

LIAO Lei, WANG Yingxia, WANG Xuechang, YANG Haoxin, LIANG Rui, ZHANG Xuan

Chinese Pharmaceutical Journal ›› 2025, Vol. 60 ›› Issue (18) : 1973-1979.

PDF(1146 KB)
PDF(1146 KB)
Chinese Pharmaceutical Journal ›› 2025, Vol. 60 ›› Issue (18) : 1973-1979. DOI: 10.11669/cpj.2025.18.012

Rapid Health Technology Assessment of Serplulimab as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 60(18): 1973-1979 https://doi.org/10.11669/cpj.2025.18.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1146 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉